Answers are grounded in this paper and cite their sources.
Background : Hyperlipidaemia contributes to cardiovascular disease, and the in- vivo effects of quercetin on lipid metabolism remain unclear. Aim of the study: To compare the effects of dietary quercetin with simvastatin in male Wistar rats with atherogenic-diet-induced hyperlipidaemia. Methods: Sixty rats divided into 12 groups (n=5) received standard or high-fat diets. 0.9% normal saline was used as a vehicle for quercetin (50, 75, or 100 mg/kg body weight) or simvastatin (0.6 mg/kg body weight) for 90 days of treatment, prophylactic, or concurrent schedules. Tissues (adipose and pancreas) total cholesterol, triglycerides and total protein, pancreatic lipase, cholecystokinin, hepatic cholesterol-7-alpha-hydroxylase (CYP7A1), 3-hydroxy-3-methylglutaryl-CoA reductase (HMG-CoA reductase) related activity and tissue morphology were assessed. Results: Quercetin at 100 mg/kg body weight produced the most consistent changes, including significantly (p<0.05) higher leves in adipose triglyceride and pancreatic total protein but lower levels of adipose tissue total cholesterol and total protein values compared to high-fat diet group. The concentration also lowered cholecystokinin, CYP7A1 activity and the HMG-CoA/mevalonate ratio and reduced the severity of high-fat-diet-associated lesions. Conclusions : High-fat-diet-associated tissue lesions may be reduced significantly after quercetin administration. Also, the dietary quercetin, especially at 100 mg/kg body weight, demonstrated lipid-lowering and tissue-preserving potentials.
No takes yet. Share an insight, caveat, or question.
Adesiyan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: